TPCW
DNA icon

TD Private Client Wealth’s Ginkgo Bioworks DNA Stock Holding History

TD Private Client Wealth’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-173
Closed -$9.19K – 1266
2023
Q1 		$9.19K Hold
173
– – ﹤0.01% 1048
2022
Q4 		$11.7K Buy
173
+96
+125% +$8.83K ﹤0.01% 986
2022
Q3 		$9.6K Buy
77
+42
+120% +$5K ﹤0.01% 1000
2022
Q2 		$3.32K Buy
+35
New +$4.27K ﹤0.01% 1098

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

TD Private Client Wealth's DNA Position: Q2 2023 in Review

TD Private Client Wealth sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 173 shares — an estimated $9.19K sold.

TD Private Client Wealth first reported a position in DNA in Q2 2022 and held it in 4 quarters. The position peaked at $11.7K in Q4 2022. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

  • TD Private Client Wealth reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
  • TD Private Client Wealth sold 173 Ginkgo Bioworks shares in Q2 2023, an estimated $9.19K.
  • TD Private Client Wealth first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 4 quarters.
  • TD Private Client Wealth's Ginkgo Bioworks position peaked at $11.7K in Q4 2022.
  • 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on TD Private Client Wealth's 13F filing for Q2 2023, filed 16 Aug 2024.